Report: Miguel Tejada also connected to Biogenesis clinic
Kansas City Royals infielder Miguel Tejada, who was suspended for 105 games on Saturday for testing positive for an amphetamine, was also reportedly tied to the investigation into the Biogenesis clinic.
ESPN.com’s Pedro Gomez reported Monday that major league baseball had the option of going after Tejada for his amphetamine use or for his ties to the Biogenesis scandal.
According to Gomez, Tejada was given the option of accepting the 105-game suspension or facing a much harsher penalty from the Biogenesis allegations. He chose the former, and he did not appeal the suspension that was handed down on Saturday.
Tejada’s 105-game suspension was the third-longest non-lifetime ban imposed by the league, after New York Yankees third baseman Alex Rodriguez’s 211-game suspension in the Biogenesis scandal and reliever Steve Howe’s 119-day penalty in 1992. Rodriguez has appealed his suspension after reportedly rejecting lesser deals with the league.
Tejada has now been tied to performance-enhancing drugs in the Mitchell Report, the Biogenesis scandal, and the latest suspension.
“I apologize to my teammates, the Royals organization and to the Kansas City fans,” Tejada said in a statement when he was suspended. “I have a medical condition that requires medication to treat. I took that medication while re-applying for a Therapeutic Use Exemption. Under the requirements of the Joint Drug Program, I made a mistake in doing so.”
The suspension could threaten the continuation of the 39-year-old Tejada’s big-league career. He would be suspended for a good portion of next season if he were to continue playing. Tejada hit .288 with three homers and 20 RBI in 53 games as a utility infielder this season.